Neuroscience
From The Guardian:
Sex hormone progesterone may save lives after brain injury
A major clinical trial will test whether the female sex hormone can minimise damage and improve recovery after brain injury
Ian Sample, San Diego
guardian.co.uk
Friday 19 February 2010 21.30 GMT
An article about the proTECT III clinical trial.
Read the article
===
Here is the ClinicalTrials.gov entry for this study: proTECT III
===
- The Futility Of Progesterone For Traumatic Brain Injury (but Hope For The Future)
Traumatic Brain Injury (TBI) is a serious public health problem that affects about 1.5 million people per year in the US, with direct and indirect medical costs of over $50 billion. Rapid intervention to reduce the risk of death and disability is crucial....
- Neuropsychology Abstract Of The Day: Tbi Clinical Trials
Today's recommended reading addresses proposed efficacy measures for use in clinical trials related to traumatic brain injury (TBI): Bagiella E, Novack TA, Ansel B, Diaz-Arrastia R, Dikmen S, Hart T, & Temkin N. Measuring Outcome in Traumatic Brain...
- Clinical Trials: Pradaxa (dabigatran Etexilate) And Stroke Prevention
From today's Guardian: Major drug trial highlights a new approach in stroke prevention The success of Pradaxa in a 44-country trial indicates a possible end to the use of the rat poison warfarin as a primary treatment to prevent stroke Press Association...
- Business World: Synthetic Blood International, Inc. And Traumatic Brain Injury
From a company press release:Synthetic Blood Announces Positive Results from Traumatic Brain Injury Preclinical Study COSTA MESA, Calif.--(BUSINESS WIRE)--Oct. 24, 2005--Synthetic Blood International, Inc. (OTCBB:SYBD) today announced that...
- Brain Injuries Still Mysterious, But Research Is Building
A recent story in the Philadelphia Inquirer reports that brain injury researchers are lifting the veil on brain injury and what they're seeing is already changing the response to brain injury in America, said Douglas Smith, MD, professor of neurosurgery,...
Neuroscience
Traumatic Brain Injury: Progesterone Clinical Trial
From The Guardian:
Sex hormone progesterone may save lives after brain injury
A major clinical trial will test whether the female sex hormone can minimise damage and improve recovery after brain injury
Ian Sample, San Diego
guardian.co.uk
Friday 19 February 2010 21.30 GMT
An article about the proTECT III clinical trial.
Read the article
===
Here is the ClinicalTrials.gov entry for this study: proTECT III
===
- The Futility Of Progesterone For Traumatic Brain Injury (but Hope For The Future)
Traumatic Brain Injury (TBI) is a serious public health problem that affects about 1.5 million people per year in the US, with direct and indirect medical costs of over $50 billion. Rapid intervention to reduce the risk of death and disability is crucial....
- Neuropsychology Abstract Of The Day: Tbi Clinical Trials
Today's recommended reading addresses proposed efficacy measures for use in clinical trials related to traumatic brain injury (TBI): Bagiella E, Novack TA, Ansel B, Diaz-Arrastia R, Dikmen S, Hart T, & Temkin N. Measuring Outcome in Traumatic Brain...
- Clinical Trials: Pradaxa (dabigatran Etexilate) And Stroke Prevention
From today's Guardian: Major drug trial highlights a new approach in stroke prevention The success of Pradaxa in a 44-country trial indicates a possible end to the use of the rat poison warfarin as a primary treatment to prevent stroke Press Association...
- Business World: Synthetic Blood International, Inc. And Traumatic Brain Injury
From a company press release:Synthetic Blood Announces Positive Results from Traumatic Brain Injury Preclinical Study COSTA MESA, Calif.--(BUSINESS WIRE)--Oct. 24, 2005--Synthetic Blood International, Inc. (OTCBB:SYBD) today announced that...
- Brain Injuries Still Mysterious, But Research Is Building
A recent story in the Philadelphia Inquirer reports that brain injury researchers are lifting the veil on brain injury and what they're seeing is already changing the response to brain injury in America, said Douglas Smith, MD, professor of neurosurgery,...